![BioLineRx Ltd](/common/images/company/N_BLRX.png)
The current BLRX market cap is 40.57M. The company's latest EPS is USD and P/E is N/A.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 4.8M | 6.86M |
Operating Income | -8.86M | -9.92M | -12.36M | -18.57M | -4.82M |
Net Income | -12.16M | -18.55M | -16.02M | -13.88M | -696k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 4.8M |
Operating Income | -28.11M | -22.93M | -24.78M | -29.16M | -49.7M |
Net Income | -25.45M | -30.02M | -27.05M | -24.95M | -60.61M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 68.65M | 58.94M | 52.86M | 63.93M | 51.6M |
Total Liabilities | 29.53M | 37.88M | 39.72M | 50.7M | 38.54M |
Total Equity | 39.11M | 21.05M | 13.13M | 13.22M | 13.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 53.57M | 47.29M | 81.39M | 76.38M | 63.93M |
Total Liabilities | 20.19M | 25.26M | 13.3M | 25.54M | 50.7M |
Total Equity | 33.38M | 22.03M | 68.09M | 50.84M | 13.22M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.02M | -17.7M | -27.6M | -22.61M | -14.11M |
Investing | 6.64M | 17.74M | 21.84M | 1.44M | 16.69M |
Financing | -49k | -183k | 3.32M | 15.06M | -894k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -22.67M | -23.21M | -23.57M | -26.24M | -22.61M |
Investing | 5.26M | 16.67M | -38.22M | 4.01M | 1.44M |
Financing | 19.19M | 17.87M | 57.75M | 20.44M | 15.06M |
Market Cap | 40.57M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 72.44M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.05 (9.39%) |
Company Name | BioLineRx Ltd |
Address |
modi’in technology park modi'in-maccabim-re'ut, center 7177871 |
Website | https://www.biolinerx.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.